Bilibili Inc. (NASDAQ:BILI – Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $15.92, but opened at $17.39. Bilibili shares last traded at $17.86, with a volume of 1,516,861 shares traded.
Analysts Set New Price Targets
A number of equities analysts have commented on BILI shares. UBS Group upgraded Bilibili from a “neutral” rating to a “buy” rating and lifted their target price for the company from $11.90 to $18.00 in a research note on Friday, May 31st. Barclays upgraded Bilibili from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $14.00 to $19.00 in a research report on Friday, August 23rd. Nomura Securities raised Bilibili from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 22nd. Daiwa America upgraded shares of Bilibili from a “moderate buy” rating to a “strong-buy” rating in a research note on Thursday, August 22nd. Finally, Bank of America raised their target price on shares of Bilibili from $18.00 to $19.00 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. Three equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.91.
Read Our Latest Research Report on BILI
Bilibili Stock Up 13.4 %
Bilibili (NASDAQ:BILI – Get Free Report) last posted its quarterly earnings results on Thursday, August 22nd. The company reported ($0.65) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.55). The company had revenue of $6.13 billion during the quarter, compared to analysts’ expectations of $6.10 billion. Bilibili had a negative return on equity of 22.44% and a negative net margin of 16.71%. Bilibili’s revenue for the quarter was up 15.5% compared to the same quarter last year. During the same period last year, the company earned ($0.43) earnings per share. Equities analysts forecast that Bilibili Inc. will post -0.4 EPS for the current year.
Institutional Trading of Bilibili
Institutional investors have recently bought and sold shares of the company. CWM LLC grew its position in Bilibili by 61.9% in the second quarter. CWM LLC now owns 2,232 shares of the company’s stock worth $34,000 after acquiring an additional 853 shares in the last quarter. Parallel Advisors LLC increased its position in Bilibili by 62.6% during the fourth quarter. Parallel Advisors LLC now owns 4,503 shares of the company’s stock worth $55,000 after buying an additional 1,734 shares during the last quarter. Sandia Investment Management LP bought a new position in Bilibili during the first quarter valued at about $112,000. Beck Bode LLC acquired a new stake in shares of Bilibili in the second quarter worth about $165,000. Finally, Vanguard Personalized Indexing Management LLC raised its stake in shares of Bilibili by 10.3% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 17,610 shares of the company’s stock valued at $272,000 after acquiring an additional 1,650 shares in the last quarter. Institutional investors and hedge funds own 16.08% of the company’s stock.
About Bilibili
Bilibili Inc provides online entertainment services for the young generations in the People's Republic of China. It offers a range of digital content, including professional user generated videos, mobile games, and value-added services, such as live broadcasting, occupationally generated videos, audio drama on Maoer, and comics on Bilibili Comic.
Featured Articles
- Five stocks we like better than Bilibili
- What are earnings reports?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- 3 Warren Buffett Stocks to Buy Now
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Bilibili Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bilibili and related companies with MarketBeat.com's FREE daily email newsletter.